CA
CGEM icon

CHI Advisors’s Cullinan Oncology CGEM Stock Holding History

CHI Advisors’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$30.9M Hold
3,414,189
– – 12.25% 3
2023
Q2 		$36.7M Buy
3,414,189
+64,729
+2% +$688K 11.15% 4
2023
Q1 		$34.3M Buy
3,349,460
+31,916
+1% +$352K 9.1% 4
2022
Q4 		$35M Buy
3,317,544
+74,359
+2% +$903K 9.32% 5
2022
Q3 		$41.6M Buy
3,243,185
+195,576
+6% +$2.63M 11.18% 3
2022
Q2 		$39.1M Buy
3,047,609
+294,562
+11% +$3.34M 14.92% 2
2022
Q1 		$28.8M Buy
2,753,047
+276,327
+11% +$3.73M 12.26% 3
2021
Q4 		$38.2M Buy
2,476,720
+231,879
+10% +$4.63M 12.68% 3
2021
Q3 		$50.7M Buy
2,244,841
+2,000
+0.1% +$53.5K 14.79% 3
2021
Q2 		$57.8M Buy
2,242,841
+40,434
+2% +$1.24M 13.44% 4
2021
Q1 		$91.8M Buy
+2,202,407
New +$89.4M 18.37% 1

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

CHI Advisors's CGEM Position: Q3 2023 in Review

CHI Advisors held its Cullinan Oncology (CGEM) position steady in Q3 2023 at 3,414,189 shares worth $30.9M. The position accounts for 12.25% of the portfolio, ranked #3.

CHI Advisors first reported a position in CGEM in Q1 2021 and has held it in 11 quarters since. The position peaked at $91.8M in Q1 2021. 106 funds tracked by Wall St. Rank hold CGEM as of Q3 2023.

  • CHI Advisors held 3,414,189 shares of Cullinan Oncology worth $30.9M as of Q3 2023.
  • CHI Advisors left its Cullinan Oncology share count unchanged in Q3 2023.
  • Cullinan Oncology made up 12.25% of CHI Advisors's portfolio in Q3 2023, its #3 holding.
  • CHI Advisors first reported a position in Cullinan Oncology in Q1 2021 and has held it in 11 quarters since.
  • CHI Advisors's Cullinan Oncology position peaked at $91.8M in Q1 2021.
  • 106 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2023.

Based on CHI Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.